DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
1W: +0.3%
1M: +0.4%
3M: +1.4%
YTD: +1.2%
1Y: +4.6%
$10.50
+0.01 (+0.10%)
After Hours: $9.83 (-0.67, -6.38%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$351.9M
52W Range10.01-10.52
Volume4
Avg Volume72,396
Beta3.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORoger Bendelac
Employees2
SectorFinancial Services
IndustryShell Companies
IPO Date2025-01-27
Websitedmaacorp.com
1 East Broward Blvd Suite 700
Fort Lauderdale, FL 33301
US
Fort Lauderdale, FL 33301
US
(954) 870-3099
About Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Drugs Made In Americ | P-Purchase | 30,000 | — | 2025-02-18 |
| Drugs Made In Americ | P-Purchase | 30,000 | — | 2025-02-18 |
| Stockwell Lynn | P-Purchase | 30,000 | — | 2025-02-18 |
| Stockwell Lynn | P-Purchase | 30,000 | — | 2025-02-18 |
| Drugs Made In Americ | P-Purchase | 400,000 | — | 2025-01-29 |